VivArt-X
PrivateLast Round
Grant
Feb 3, 2026
Total Funding Raised
$2.26M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
VivArt-X operates in Healthcare & Life Sciences and is based in Eindhoven. Its latest recorded funding round was a Grant round in February 2026.
VivArt-X is a medtech company that develops a platform technology for advanced tissue engineering, with a first product focused on a bio-absorbable scaffold for soft tissue regeneration after breast cancer surgery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
VivArt-X Comparables
Compare VivArt-X with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Healshape | 90% | |
| GenesisTissue Inc. | 85% | |
| Tensive | 84% |
For institutional investors. Book with your work email.
VivArt-X Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 3, 2026 | ||||
| Grant | Dec 1, 2025 | ||||
| Pre Seed | May 8, 2024 | ||||
| Grant | Dec 5, 2023 | ||||
| Pre Seed | Nov 20, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
VivArt-X Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metropoolregio Eindhoven | Grant |
| Brabantse Ontwikkelings Maatschappij | Pre Seed |
| Eindhoven University of Technology | Grant |
| TU/e Participations | Pre Seed |
| Maastricht University | Grant |
| Province of Noord-Brabant | Grant |
| Smart BioMaterials Consortium | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2026
Received funding from Stimuleringsfonds Metropoolregio Eindhoven.
- Dec 1, 2025
Secured $3.24M from European Union and Dutch government.
For institutional investors. Book with your work email.
VivArt-X Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about VivArt-X's valuation, stock price, and market status.
Is VivArt-X a public or private company?
VivArt-X is a private company.
What is the current stock price of VivArt-X?
VivArt-X is a private company, so its shares have no public market price. Caplight tracks VivArt-X's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is VivArt-X worth (valuation)?
Valuation information for VivArt-X is not publicly available.
Can I buy VivArt-X stock?
VivArt-X shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was VivArt-X's last funding round?
VivArt-X's most recent funding round was Grant on February 3, 2026.
Who are the main investors in VivArt-X?
Key investors in VivArt-X include StartGreen Capital.
Will VivArt-X IPO soon?
No public IPO plans have been announced for VivArt-X.
How can I track VivArt-X secondary market activity?
Caplight tracks bids, offers, and trades in VivArt-X's shares on secondary markets.